Services We Offer
Endocrine Technology, LLC is a Code name for ET or Extra Terrestrial or Immortal Biotechnology Company
Our company is detailed at https://www.etcovid-19.com
Our Celestial Technology advances are in longevity and age-related diseases, which “Advances Recent Advances in Genomics and Fundamentals of Immunology” from mere concept to bedside applications. These advances, when skillfully and safely applied, will allow one to live a long, healthy life and provide prophylaxis and therapy for major life-threatening diseases.
Our patents are approved in both the USA and India, and numerous patents are being filed.
As a physician-based Biotechnology Company, we offer direct super consultancy services to patients and consumers who wish to prolong healthy living, boost host immunity, and develop prophylaxis and therapy for age-related diseases.
ETBOND Technology: Empowering Life-Saving Solutions
Endocrine Technology LLC is a New York-based biotechnology company, pioneering the use of ETBOND Technology, a patented platform that transforms genomics and immunology into real-world healthcare applications. Our ETBOND Technology has been approved in both the USA and India, offering a broad range of therapeutic solutions for age-related diseases, cancer, autoimmune diseases, cardiovascular conditions, and much more.
Our technology is a catalyst for the Right to Try Law, providing millions of patients with access to life-saving medicines in a cost-effective manner, not just in the United States, but globally. By integrating ETBOND Technology into the healthcare landscape, we are redefining the future of medical treatments, advancing therapeutics decades ahead of traditional approaches.
Here’s how ETBOND Technology is impacting healthcare:
Cancer Care
ETBOND Technology serves as an advanced immune checkpoint inhibitor, empowering the body’s immune system to target and eliminate cancer cells. This technology builds on the 2018 Nobel Prize in medicine for T and B cell advancements, which enhance the immune response to cancer, offering new hope in cancer therapy.
Autoimmune Diseases
Leveraging the T and B cell reprogramming advances, which won the 2025 Nobel Prize, ETBOND Technology reprograms the immune system to effectively treat autoimmune diseases. Our approach goes beyond these breakthroughs to re-engineer diabetes and its associated vascular diseases.
Transplant Technology
Our innovative technology addresses critical issues in organ transplants, such as heart, kidney, lung, and liver transplants. ETBOND Technology fills the gap in preventing early organ rejection, providing a sustainable solution for islet cell transplants and potentially offering a cure for Type 1 diabetes.
Orphan Diseases
ETBOND Technology offers solutions for orphan diseases, particularly those affecting blood and kidneys. Our treatments address conditions like atypical hemolytic disorders, blood transfusion incompatibilities, and complement-mediated kidney diseases, which are often difficult to treat with conventional therapies.
Pandemics and Infectious Diseases
In the face of global health challenges such as COVID-19, ETBOND Technology provides cutting-edge solutions to combat pandemics. Our technology works to address the immune evasion mechanisms of SARS-CoV-2, offering a novel way to manage recurring pandemics and emerging infectious diseases.
Cardiovascular Diseases
ETBOND Technology provides a breakthrough solution for cardiovascular diseases, such as acute myocardial infarction. It simultaneously targets lipid disorders, inflammation, and coagulation disorders, providing prophylaxis and therapy for cardiovascular conditions.
https://youtu.be/ZPFEet1YBI4?si=qJIM8X_Cpk_9YLrGEye Diseases and Blindness
Our technology tackles inflammatory eye diseases, a leading cause of blindness, such as age-related macular degeneration and diabetic retinopathy. By advancing treatments in this area, ETBOND Technology helps preserve vision and improve long-term eye health.
Hemodialysis and Chronic Renal Failure Treatment
Our reformulated Sodium Polystyrene Sulfonate, delivered in Polysulfone fibers, revolutionizes hemodialysis therapy, significantly reducing the risk of pulmonary complications. This technology, grounded in recent advances in genomics and immunology, improves safety and enhances the comfort of dialysis patients globally.
Cutting-Edge Drug Development
The ETBOND Technology platform has led to the reformulation of generic drugs, such as Sodium Polystyrene Sulfonate, into highly effective treatments for chronic renal failure. Our drug helps reduce high potassium levels through its ion exchange properties and is approved for global use in millions of patients. Through clinical trials and patient safety data collected at the ETBOND Clinic, we’ve achieved a 100-fold increase in safety for these therapies.
Future of Healthcare
By embracing the transformative power of genomics, artificial intelligence, and biotechnology, we are on a path to revolutionize global healthcare. ETBOND Technology promises to provide accessible, life-saving therapies that will address major health challenges worldwide, ensuring a better quality of life for all.
Our Ability to Transcend
- Biotechnology business model (infrastructure, expert manpower resources, and money
- Drug development barriers (drug discovery to clinical applications and its associated costs)
- Regulatory concerns at FDA levels (Marketing authorization)
- Human safety data
- Human efficacy data and
- Our ability to transcend steps a to f is related to the extensive database of major life-threatening diseases and its skillful use to benefit patients directly.
Our super consultancy services are not found anywhere in this mortal world —involve working with patients, consumers, medical experts and specialists in different diseases.
We have a vast array of laboratory and imaging services at our disposal to guide patients through evidence-based medicine and take them beyond toward a celestial path of long healthy living.
We accept most but select insurances in the USA and involve the standard creation of electronic health record systems, monitoring of consulting services and their responses, and evidence-based medicine guidance.
Our ability to help you with life-threatening diseases is the most adventurous path we have taken in this life. For this reason, we are proud to say, “The name is Bond…ETBOND Technology,” an approved trade name in the USA.